Skip to main content

Your search for “Infectious Disease” returned 333 results

Medtech Meets Cleantech: Malaria Vaccine Candidate Produced from Algae

February 18, 2015

Researchers at University of California, San Diego School of Medicine used algae as a mini-factory to produce a malaria parasite protein. The algae-produced protein, paired with an immune-boosting cocktail suitable for use in humans, generated antibodies in mice that nearly eliminated mosquito infection by the malaria parasite. The method is…

UC San Diego to Advance Stem Cell Therapies in New Space Station Lab

April 8, 2020

UC San Diego and Space Tango received a NASA award to develop the first dedicated stem cell research laboratory within the International Space Station.

Cross Border Effort to Vaccinate 10,000 Maquiladora Workers

May 25, 2021

A coalition of six U.S. subsidiary companies have sponsored a COVID-19 mobile clinic to vaccinate 10,000 maquiladora workers employed in Baja California, Mexico. UC San Diego Health is vaccinating about 1,500 workers daily.

Charting Shots

October 7, 2021

…in prevention, and a disease dodged is harder to count, though the World Health Organization estimates 2.5 million deaths are prevented each year due to vaccinations. In the time of COVID, the importance of vaccines has never been more obvious or pressing. The SARS-CoV-2 virus has killed more than 4.5…

Coronavirus Jumped to Humans at Least Twice at Market in Wuhan, China

July 26, 2022

In a pair of related studies, UC San Diego researchers show that the origin of the COVID-19 pandemic was at a Chinese market and resulted from at least two instances of the SARS-CoV-2 virus jumping from live animal hosts to humans working or shopping there.

Research Growth Tops $1.76B With Tremendous Portfolio of Discovery and Invention

August 8, 2023

University of California San Diego earned $1.76 billion in research funding last fiscal year, a 6 percent increase over the previous year.

UC San Diego Health Joins International Clinical Trial to Test Coronavirus Vaccine

October 1, 2020

UC San Diego Health will be a test site for a third, major Phase III clinical trial to assess a vaccine candidate for the novel coronavirus that causes COVID-19. Sponsored by Janssen Pharmaceuticals, the trial will recruit up to 60,000 participants at sites in the United States and worldwide.

Amanda Gosman Changes Face of Plastic Surgery

May 16, 2019

…the global burden of diseases that could be treated through surgery as a tremendous global public health opportunity. The Lancet Commission on Global Surgery estimates that 5 billion people lack access to safe and affordable surgical care and anesthesia. Because of this, many easily treatable conditions become deadly or disabling.…

Nanosponges Could Intercept Coronavirus Infection

June 17, 2020

Nanoparticles cloaked in human lung cell membranes and human immune cell membranes can attract and neutralize the SARS-CoV-2 virus in cell culture, causing the virus to lose its ability to hijack host cells and reproduce.

Beneficial Skin Bacteria Protect Against Skin Cancer

February 28, 2018

Science continues to peel away layers of the skin microbiome to reveal its protective properties. In a study published in Science Advances on February 28, University of California San Diego School of Medicine researchers report a potential new role for some bacteria on the skin: protecting against cancer.

Category navigation with Social links